Market Research Logo

Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017

Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Epilepsy patients study in a new report ‘Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Epilepsy epidemiology, Epilepsy diagnosed patients, and Epilepsy treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Epilepsy derived from epidemiological analysis, percentage of patients diagnosed with Epilepsy, and percentage of patients treated with a therapy.

The study helps executives estimate Epilepsy market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Epilepsy prevalence, Epilepsy diagnosis rate, and Epilepsy treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Epilepsy Patient Flow
  • Epilepsy Prevalence
  • Epilepsy Diagnosed Patients
  • Epilepsy Treated Patients


1. Epilepsy: Disease Definition
2. Epilepsy Patient Flow in Europe
2A. Epilepsy Prevalence in Europe
2B. Epilepsy Diagnosed Patients in Europe
2C. Epilepsy Treated Patients in Europe
3. Epilepsy Patient Flow in Germany
3A. Epilepsy Prevalence in Germany
3B. Epilepsy Diagnosed Patients in Germany
3C. Epilepsy Treated Patients in Germany
4. Epilepsy Patient Flow in France
4A. Epilepsy Prevalence in France
4B. Epilepsy Diagnosed Patients in France
4C. Epilepsy Treated Patients in France
5. Epilepsy Patient Flow in Spain
5A. Epilepsy Prevalence in Spain
5B. Epilepsy Diagnosed Patients in Spain
5C. Epilepsy Treated Patients in Spain
6. Epilepsy Patient Flow in Italy
6A. Epilepsy Prevalence in Italy
6B. Epilepsy Diagnosed Patients in Italy
6C. Epilepsy Treated Patients in Italy
7. Epilepsy Patient Flow in UK
7A. Epilepsy Prevalence in UK
7B. Epilepsy Diagnosed Patients in UK
7C. Epilepsy Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Epilepsy Patient Flow in Europe, 2016
Table 2: Epilepsy Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Epilepsy Patient Flow in Germany, 2016
Table 4: Epilepsy Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Epilepsy Patient Flow in France, 2016
Table 6: Epilepsy Patient Flow Forecast in France, 2016 - 2025
Table 7: Epilepsy Patient Flow in Spain, 2016
Table 8: Epilepsy Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Epilepsy Patient Flow in Italy, 2016
Table 10: Epilepsy Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Epilepsy Patient Flow in UK, 2016
Table 12: Epilepsy Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Epilepsy Patient Flow in Europe, 2016
Figure 2: Epilepsy Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Epilepsy Patient Flow in Germany, 2016
Figure 4: Epilepsy Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Epilepsy Patient Flow in France, 2016
Figure 6: Epilepsy Patient Flow Forecast in France, 2016 - 2025
Figure 7: Epilepsy Patient Flow in Spain, 2016
Figure 8: Epilepsy Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Epilepsy Patient Flow in Italy, 2016
Figure 10: Epilepsy Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Epilepsy Patient Flow in UK, 2016
Figure 12: Epilepsy Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report